Varex Imaging Corporation EBITDA | VREX

Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.^[1]

EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.

EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.

However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.

Annual EBITDA Varex Imaging Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-4.6 M	53.3 M	96.6 M	107 M	94.6 M	-11.4 M	84.9 M	86.7 M	111 M	124 M	140 M	186 M	179 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
186 M	-11.4 M	96 M

Quarterly EBITDA Varex Imaging Corporation

2026-Q3	2026-Q2	2026-Q1	2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-79.7 M	25.8 M	21.1 M	21.1 M	-	-79.7 M	23.1 M	17.4 M	-	11 M	11.3 M	9.3 M	-	27.6 M	19 M	17.6 M	-	26.7 M	30.3 M	18.8 M	-	36.2 M	20.1 M	9.8 M	-3.5 M	-15.4 M	5.8 M	-	48.2 M	18.7 M	18.1 M	20.2 M	54.1 M	17.8 M	20.2 M	18.5 M	67.7 M	24 M	18.5 M	21.7 M	83.3 M	32.8 M	21.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
83.3 M	-79.7 M	17.8 M

References

Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.

EBITDA of other stocks in the Medical devices industry

Issuer	EBITDA	Price	% 24h	Market Cap	Country
Conformis CFMS	-42.2 M	-	-	$ 16.4 M	USA
Boston Scientific Corporation BSX	4.98 B	$ 43.92	0.06 %	$ 65 B	USA
Cognyte Software Ltd. CGNT	25.2 M	$ 8.52	0.06 %	$ 621 M	Israel
ClearPoint Neuro CLPT	-23.4 M	$ 14.83	1.51 %	$ 420 M	USA
CONMED Corporation CNMD	120 M	$ 45.38	0.44 %	$ 1.41 B	USA
Cytosorbents Corporation CTSO	-13.5 M	$ 4.38	1.86 %	$ 273 M	USA
Delcath Systems DCTH	898 K	$ 15.6	0.75 %	$ 559 M	USA
Eargo EAR	-106 M	-	-	$ 10.2 M	USA
Medigus Ltd. MDGS	-9.9 M	-	10.28 %	$ 55.5 M	Israel
Electromed ELMD	14.7 M	$ 27.88	0.07 %	$ 230 M	USA
Cutera CUTR	-148 M	-	-10.19 %	$ 1.99 M	USA
Establishment Labs Holdings ESTA	-32.8 M	$ 65.97	0.59 %	$ 1.95 B	Costa-rica
Edwards Lifesciences Corporation EW	1.42 B	$ 86.29	0.66 %	$ 50.5 B	USA
Nemaura Medical NMRD	-9.15 M	-	-17.8 %	$ 2.74 M	Britain
Helius Medical Technologies HSDT	-244 M	$ 2.94	1.38 %	$ 64.8 M	USA
AdaptHealth Corp. AHCO	473 M	$ 5.64	1.26 %	$ 762 M	USA
Inogen INGN	-9.55 M	$ 5.36	2.49 %	$ 143 M	USA
InMode Ltd. INMD	86.1 M	$ 14.26	0.49 %	$ 922 M	Israel
Inspire Medical Systems INSP	64.9 M	$ 70.5	2.46 %	$ 2.07 B	USA
IRIDEX Corporation IRIX	-2.05 M	$ 0.63	0.16 %	$ 10.7 M	USA
IRadimed Corporation IRMD	27.3 M	$ 85.76	0.66 %	$ 1.09 B	USA
Neovasc NVCN	-31.1 M	-	-	$ 111 M	Canada
AxoGen AXGN	-1.19 M	$ 43.39	0.16 %	$ 2 B	USA
Align Technology ALGN	783 M	$ 146.78	0.79 %	$ 10.6 B	USA
LENSAR LNSR	-21 M	$ 6.92	0.28 %	$ 82.7 M	USA
Sientra SIEN	-62.4 M	-	-16.59 %	$ 10.3 M	USA
Silk Road Medical, Inc SILK	-56.6 M	-	-	$ 1.07 B	USA
Medtronic PLC MDT	9.42 B	$ 88.64	0.98 %	$ 114 B	USA
MiMedx Group MDXG	78.8 M	$ 4.67	0.1 %	$ 690 M	USA
Surgalign Holdings SRGA	-76.3 M	-	-32.98 %	$ 1.68 M	USA
ShockWave Medical SWAV	169 M	-	-	$ 12.3 B	USA
Myomo MYO	-13.5 M	$ 1.61	0.6 %	$ 67.4 M	USA
Nano-X Imaging Ltd. NNOX	-77 M	$ 0.64	0.02 %	$ 41.5 M	Israel
InspireMD NSPR	426 M	$ 0.7	0.71 %	$ 45 M	Israel
Orthofix Medical OFIX	-4.11 M	$ 9.44	3.06 %	$ 374 M	Curacao
Outset Medical OM	-62.4 M	$ 3.05	1.29 %	$ 46.4 K	USA
Insulet Corporation PODD	564 M	$ 136.13	0.26 %	$ 9.58 B	USA
Quanterix Corporation QTRX	-110 M	$ 3.27	2.83 %	$ 139 M	USA
Titan Medical TMDI	-31 M	-	-26.32 %	$ 19.6 M	Canada
AVITA Medical RCEL	-40.2 M	$ 11.84	2.25 %	$ 330 M	Australia
Natus Medical Incorporated NTUS	51.9 M	-	1.94 %	$ 1.05 B	USA
Cardiovascular Systems CSII	-32.1 M	-	0.15 %	$ 844 M	USA
Apyx Medical Corporation APYX	-5.79 M	$ 2.96	4.59 %	$ 122 M	USA
Sintx Technologies SINT	-10.4 M	$ 1.88	0.53 %	$ 5.21 M	USA
Smith & Nephew plc SNN	1.37 B	$ 26.91	0.86 %	$ 23.3 B	Britain
Accuray Incorporated ARAY	-18.5 M	$ 0.22	1.84 %	$ 27 M	USA
Inari Medical NARI	-7.14 M	-	-	$ 4.23 B	USA
Sensus Healthcare SRTS	-9.91 M	$ 2.94	1.03 %	$ 48 M	USA
Bruker Corporation BRKR	288 M	$ 64.18	0.28 %	$ 9.74 B	USA
Stryker Corporation SYK	6.46 B	$ 272.36	0.97 %	$ 104 B	USA